Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.5 GBX | 0.00% | +3.45% | -68.09% |
May. 20 | IQ-AI subsidiary gets second FDA rare paediatric disease designation | AN |
May. 20 | IQ-AI's Imaging Biometrics Gets Second Rare Disease Designation for Drug Candidate | MT |
Business Summary
Sales per Business
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Software
100.0
%
| 0 | nan % | 1 | 100.0 % | - |
Sales per region
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +13.72% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Trevor Brown
CEO | Chief Executive Officer | 78 | 15-02-12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Trevor Brown
CEO | Chief Executive Officer | 78 | 15-02-12 |
Vinod Kaushal
BRD | Director/Board Member | 60 | 17-01-19 |
Director/Board Member | - | 19-12-17 | |
Brett Skelly
BRD | Director/Board Member | - | 21-09-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 221,709,789 | 136,845,642 ( 61.72 %) | 0 | 61.72 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-68.09% | 4.25M | |
-22.13% | 7.91B | |
+76.16% | 4.52B | |
+8.56% | 2.74B | |
-2.80% | 2.66B | |
-50.41% | 2.02B | |
-19.59% | 1.68B | |
-20.07% | 1.51B | |
+19.31% | 1.24B | |
-45.78% | 1.1B |
- Stock Market
- Equities
- IQAI Stock
- Company IQ-AI Limited